weazel I agree it's incredible we are close to P3 in a potential blockbuster drug and we are worth 50m usd. it just shows you how little faith the market has in management / the ability to get funding and a deal.
if and it is a very big if it all comes together in the next few months then I would expect a massive and rapid re rating.
dunno what their chances are but I'm rooting for them and I'm hopeful that in the end the science will win out.
Chart, page-4255
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 23.3¢ | $74.59K | 314.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 28833 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 21738 | 1 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |